466 related articles for article (PubMed ID: 22086874)
1. Dysfunctional telomeres promote genomic instability and metastasis in the absence of telomerase activity in oncogene induced mammary cancer.
Bojovic B; Crowe DL
Mol Carcinog; 2013 Feb; 52(2):103-17. PubMed ID: 22086874
[TBL] [Abstract][Full Text] [Related]
2. Telomerase deficiency and telomere dysfunction inhibit mammary tumors induced by polyomavirus middle T oncogene.
Jaskelioff M; Song W; Xia J; Liu C; Kramer J; Koido S; Gendler SJ; Calderwood SK; Gong J
Oncogene; 2009 Dec; 28(48):4225-36. PubMed ID: 19734944
[TBL] [Abstract][Full Text] [Related]
3. Haploinsufficiency of the Nijmegen breakage syndrome 1 gene increases mammary tumor latency and metastasis.
Wan R; Crowe DL
Int J Oncol; 2012 Jul; 41(1):345-52. PubMed ID: 22576691
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity in normal and malignant murine tissues.
Chadeneau C; Siegel P; Harley CB; Muller WJ; Bacchetti S
Oncogene; 1995 Sep; 11(5):893-8. PubMed ID: 7675448
[TBL] [Abstract][Full Text] [Related]
5. Telomere dysfunction promotes metastasis in a TERC null mouse model of head and neck cancer.
Bojovic B; Crowe DL
Mol Cancer Res; 2011 Jul; 9(7):901-13. PubMed ID: 21593138
[TBL] [Abstract][Full Text] [Related]
6. Telomere length and telomerase activity impact the UV sensitivity syndrome xeroderma pigmentosum C.
Stout GJ; Blasco MA
Cancer Res; 2013 Mar; 73(6):1844-54. PubMed ID: 23288511
[TBL] [Abstract][Full Text] [Related]
7. Absence of telomerase and shortened telomeres have minimal effects on skin and pancreatic carcinogenesis elicited by viral oncogenes.
Argilla D; Chin K; Singh M; Hodgson JG; Bosenberg M; de Solórzano CO; Lockett S; DePinho RA; Gray J; Hanahan D
Cancer Cell; 2004 Oct; 6(4):373-85. PubMed ID: 15488760
[TBL] [Abstract][Full Text] [Related]
8. Constitutive telomerase expression promotes mammary carcinomas in aging mice.
Artandi SE; Alson S; Tietze MK; Sharpless NE; Ye S; Greenberg RA; Castrillon DH; Horner JW; Weiler SR; Carrasco RD; DePinho RA
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8191-6. PubMed ID: 12034875
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
Akli S; Van Pelt CS; Bui T; Multani AS; Chang S; Johnson D; Tucker S; Keyomarsi K
Cancer Res; 2007 Aug; 67(15):7212-22. PubMed ID: 17671189
[TBL] [Abstract][Full Text] [Related]
10. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activation in mouse mammary tumors: lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation.
Broccoli D; Godley LA; Donehower LA; Varmus HE; de Lange T
Mol Cell Biol; 1996 Jul; 16(7):3765-72. PubMed ID: 8668193
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of telomerase limits the growth of human cancer cells.
Hahn WC; Stewart SA; Brooks MW; York SG; Eaton E; Kurachi A; Beijersbergen RL; Knoll JH; Meyerson M; Weinberg RA
Nat Med; 1999 Oct; 5(10):1164-70. PubMed ID: 10502820
[TBL] [Abstract][Full Text] [Related]
13. Lung alveolar integrity is compromised by telomere shortening in telomerase-null mice.
Lee J; Reddy R; Barsky L; Scholes J; Chen H; Shi W; Driscoll B
Am J Physiol Lung Cell Mol Physiol; 2009 Jan; 296(1):L57-70. PubMed ID: 18952756
[TBL] [Abstract][Full Text] [Related]
14. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
15. Stat3 is required for anchorage-independent growth and metastasis but not for mammary tumor development downstream of the ErbB-2 oncogene.
Barbieri I; Quaglino E; Maritano D; Pannellini T; Riera L; Cavallo F; Forni G; Musiani P; Chiarle R; Poli V
Mol Carcinog; 2010 Feb; 49(2):114-20. PubMed ID: 20027636
[TBL] [Abstract][Full Text] [Related]
16. Telomerase inhibition in RenCa, a murine tumor cell line with short telomeres, by overexpression of a dominant negative mTERT mutant, reveals fundamental differences in telomerase regulation between human and murine cells.
Sachsinger J; González-Suárez E; Samper E; Heicappell R; Müller M; Blasco MA
Cancer Res; 2001 Jul; 61(14):5580-6. PubMed ID: 11454711
[TBL] [Abstract][Full Text] [Related]
17. Telomere length, telomeric proteins and genomic instability during the multistep carcinogenic process.
Raynaud CM; Sabatier L; Philipot O; Olaussen KA; Soria JC
Crit Rev Oncol Hematol; 2008 May; 66(2):99-117. PubMed ID: 18243729
[TBL] [Abstract][Full Text] [Related]
18. Telomere dysfunction results in enhanced organismal sensitivity to the alkylating agent N-methyl-N-nitrosourea.
González-Suárez E; Goytisolo FA; Flores JM; Blasco MA
Cancer Res; 2003 Nov; 63(21):7047-50. PubMed ID: 14612493
[TBL] [Abstract][Full Text] [Related]
19. Pathways connecting telomeres and p53 in senescence, apoptosis, and cancer.
Artandi SE; Attardi LD
Biochem Biophys Res Commun; 2005 Jun; 331(3):881-90. PubMed ID: 15865944
[TBL] [Abstract][Full Text] [Related]
20. Severe growth defect in mouse cells lacking the telomerase RNA component.
Niida H; Matsumoto T; Satoh H; Shiwa M; Tokutake Y; Furuichi Y; Shinkai Y
Nat Genet; 1998 Jun; 19(2):203-6. PubMed ID: 9620783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
